MoneyWorks4Me

Laurus Labs informs about analyst meeting

13 Mar 2023 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), Laurus Labs has informed that Analyst/Institutional Investor meeting is scheduled on March 13, 2023 with Motilal Oswal in the form of In-Person Meetings. No Unpublished Price Sensitive Information will be shared during the meetings

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..